CC vs PATH
Chemours Co (CC) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Chemours Co (CC) is a specialty chemicals company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported CC revenue for 2024-12-31 was $1.36B. Net income was -$8.0M. Revenue was down 9.9% from 2024-09-30 to 2024-12-31. CC currently screens at market cap $1.94B and trailing P/E 71.8.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
CC currently screens at market cap $1.94B and trailing P/E 71.8. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the CC and PATH stock pages for the full models.
Not investment advice.